Skip to content
OpenCapital
Get started

Lexicon Pharmaceuticals LXRX Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

CONMED logo
CONMEDCNMD
$6.23M+6.4%
Century Communities logo
Century CommunitiesCCS
$22.22M+279%
EyePoint, Inc. logo
EyePoint, Inc. EYPT
$4.06M+16.7%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Equitable Holdings logo
Equitable HoldingsEQH
$371M-5.1%
Proto Labs logo
Proto LabsPRLB
$128.08M+5.2%

Segments

By segment

See full
Reportable Segment$3.08M+9.9%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+273%
Enterprise value$976.73M+219%
P/S14.2×+5.7×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×